LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 932974
BOSTON, MA
Position in VRTX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,647,653
-$74,651 QoQ
Shares Held
3,317
-14.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#706
of 1,705 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $43,678,237 across 12 Biotechnology names. VRTX ranks #2 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,875 | $41,075,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,317 | $1,647,653 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,533 | $461,478 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
500 | $268,475 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,000 | $77,400 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
|
7,500 | $73,650 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
278 | $32,545 | |
| 8 | BNTX |
BioNTech SE
|
190 | $17,679 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,647,653 | 3,317 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,722,304 | 3,857 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,803,466 | 3,978 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,546,978 | 3,950 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $331,228 | 744 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $336,465 | 694 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $279,473 | 694 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $306,952 | 660 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $262,014 | 559 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $233,667 | 559 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $222,568 | 547 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $190,213 | 547 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $192,494 | 547 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $170,137 | 540 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $114,068 | 395 | Shares | Sole | 2023-03-02 | |
| 2022-09-30 | $114,368 | 395 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $111,307 | 395 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $79,595 | 305 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $66,978 | 305 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $57,137 | 315 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $68,554 | 340 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $179,854 | 761 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $254,432 | 935 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $271,439 | 935 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $162,995 | 685 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||